Barclays analyst Adam Seiden lowered the firm’s price target on Blue Bird (BLBD) to $50 from $54 and keeps an Overweight rating on the shares post the fiscal Q2 report. Blue Bird narrowed but reaffirmed the midpoint of its fiscal 2025 EBITDA range and Q3 is on pace to be another record quarter, the analyst tells investors in a research note. The firm says resiliency in on-highway markets is increasingly harder to find and Blue Bird “still relatively has it.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLBD: